Patent 11964151 was granted and assigned to Neuspera Medical on April, 2024 by the United States Patent and Trademark Office.
Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided.